Dr Christopher Turner is the Head of Life Science. His research studies animals at all levels, from their molecular and cell biology to their behaviour and ecology. He obtained his PhD from UCL and has worked in both academia and the pharmaceutical industry. Prior to joining the University of Suffolk, Dr Turner worked at the Massachusetts Institute of Technology (MIT) in the USA, where he led a research programme focused on identifying genes that are essential for the development of the vertebrate heart and the vasculature. He has also worked at Cancer research UK's London research Institute and GlaxoSmithKline.
- Vertebrate development
- Cell adhesion and migration
- Extracellular Matrix
- Ecology-led drug discovery
- Scientific imaging
- Turner CJ, Badu-Nkansah K, Hynes RO (2017) Endothelium-derived fibronectin regulates neonatal morphogenesis in an autocrine fashion. Angiogenesis. 20(4), 519-531.
- Turner CJ, Badu-Nkansah K, Crowley D, van der Flier A, Hynes RO (2015) alpha 5 and alpha v integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo. Development. 142(4), 797-808.
- Turner CJ, Badu-Nkansah K, Crowley D, van der Flier A, Hynes RO (2014) Integrin-a5b1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation. Developmental Biology. 392(2), 381-92.
- Nakayama A, Nakayama M, Turner CJ, Hoeing S, Lepore JJ, Adams RH (2013) Ephrin-B2 controls PDGFRb internalisation and signalling. Genes & Development. 27(23), 2576-89.
- Kuijper S, Turner CJ, Adams RH (2007) Regulation of angiogenesis by Eph-ephrin interactions. Trends. Cardiovasc. Med. 17(5), 145-51.
- Foo SS*, Turner CJ*, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH (2006) Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell. 124(1), 161-73.